Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/31700
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-03-23T06:38:47Z | - |
dc.date.available | 2023-03-23T06:38:47Z | - |
dc.date.issued | 2007-09 | - |
dc.identifier.citation | Dirican, M. vd. (2007). "Oxidative status and prevalent cardiovascular disease in patients with chronic renal failure treated by hemodialysis". Clinical Nephrology, 68(3), 144-150. | en_US |
dc.identifier.issn | 0301-0430 | - |
dc.identifier.uri | https://doi.org/10.5414/cnp68144 | - |
dc.identifier.uri | https://www.dustri.com/article_response_page.html?artId=1003&doi=10.5414/CNP68144&L=0 | - |
dc.identifier.uri | http://hdl.handle.net/11452/31700 | - |
dc.description.abstract | Background: Hemodialysis (1413) patients are exposed to oxidative stress which contributes to cardiovascular disease (CVD). The purpose of this study was to investigate the oxidative and antioxidative status in HD patients with (CVD+, n = 38) and without (CVD-, n = 67) prevalent CVD. Patients and methods: A total of 105 HD patients and 21 healthy controls were assessed for lipid peroxidation indices (plasma malondialdehyde (MDA)), oxidizability of apolipoprotein B-containing lipoproteins (apo B-AMDA) and red blood cells (RBC-MDA) together with various components of the antioxidant system in plasma (paraoxonase/arylesterase activities, total carotenoids, vitamins C and E) and RBC (superoxide dismutase and glutathione peroxidase activities). Results: Plasma MDA and RBC-MDA were significantly higher, vitamin C and total carotenoid levels were significantly lower in both CVD+ and CVD- HD groups than in the control group. Plasma MDA levels were significantly higher and serum paraoxonase activity, uric acid and albumin levels were significantly lower in patients with CVD+ HD patients compared to those of the CVD- patients. Conclusion: This study suggests that the elevated level of plasma MDA and the lower activity of paraoxonase could contribute to the increased incidence of cardiovascular disease in hemodialysis patients. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Dustri Verlag | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Cardiovascular disease | en_US |
dc.subject | Low-density-lipoprotein | en_US |
dc.subject | Hemodialysis | en_US |
dc.subject | Malondialdehyde | en_US |
dc.subject | Oxidative status | en_US |
dc.subject | Paraoxonase activity | en_US |
dc.subject | Serum paraoxonase activity | en_US |
dc.subject | Uremic patients | en_US |
dc.subject | Plasma | en_US |
dc.subject | Malondialdehyde | en_US |
dc.subject | Stress | en_US |
dc.subject | Susceptibility | en_US |
dc.subject | Inflammation | en_US |
dc.subject | Dialysis | en_US |
dc.subject | Risk | en_US |
dc.subject | Urology & nephrology | en_US |
dc.title | Oxidative status and prevalent cardiovascular disease in patients with chronic renal failure treated by hemodialysis | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000250751700002 | tr_TR |
dc.identifier.scopus | 2-s2.0-34548528955 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Biyokimya Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-2593-7196 | tr_TR |
dc.contributor.orcid | 0000-0002-0909-618X | tr_TR |
dc.identifier.startpage | 144 | tr_TR |
dc.identifier.endpage | 150 | tr_TR |
dc.identifier.volume | 68 | tr_TR |
dc.identifier.issue | 3 | tr_TR |
dc.relation.journal | Clinical Nephrology | en_US |
dc.contributor.buuauthor | Dirican, Melahat | - |
dc.contributor.buuauthor | Sarandöl, Emre | - |
dc.contributor.buuauthor | Serdar, Zehra | - |
dc.contributor.buuauthor | Ocak, Nihal | - |
dc.contributor.buuauthor | Dilek, Kamil | - |
dc.contributor.researcherid | AAH-6200-2021 | tr_TR |
dc.contributor.researcherid | ABE-1716-2020 | tr_TR |
dc.identifier.pubmed | 17915616 | tr_TR |
dc.subject.wos | Urology & nephrology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q3 | en_US |
dc.contributor.scopusid | 6601919847 | tr_TR |
dc.contributor.scopusid | 55943324800 | tr_TR |
dc.contributor.scopusid | 57222002284 | tr_TR |
dc.contributor.scopusid | 23989248600 | tr_TR |
dc.contributor.scopusid | 56005080200 | tr_TR |
dc.subject.scopus | Hemodialysis; Oxidative Stress; Chronic Kidney Failure | en_US |
dc.subject.emtree | Albumin | en_US |
dc.subject.emtree | Alpha tocopherol | en_US |
dc.subject.emtree | Apolipoprotein B | en_US |
dc.subject.emtree | Aryldialkylphosphatase | en_US |
dc.subject.emtree | Arylesterase | en_US |
dc.subject.emtree | Ascorbic acid | en_US |
dc.subject.emtree | Carotenoid | en_US |
dc.subject.emtree | Glutathione peroxidase | en_US |
dc.subject.emtree | Malonaldehyde | en_US |
dc.subject.emtree | Superoxide dismutase | en_US |
dc.subject.emtree | Uric acid | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Albumin blood level | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Cardiovascular disease | en_US |
dc.subject.emtree | Cell level | en_US |
dc.subject.emtree | Chronic kidney failure | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Enzyme activity | en_US |
dc.subject.emtree | Enzyme blood level | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Hemodialysis | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Incidence | en_US |
dc.subject.emtree | Lipid peroxidation | en_US |
dc.subject.emtree | Major clinical study | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Oxidative stress | en_US |
dc.subject.emtree | Prevalence | en_US |
dc.subject.emtree | Uric acid blood level | en_US |
dc.subject.emtree | Vitamin blood level | en_US |
Appears in Collections: | PubMed Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.